Becton Dickinson (BDX)
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD® Pyxis™ Pro Dispensing Solution and BD® Incada™ Connected Care Platform in
Quick, reliable access to medications at the point of care is essential to effective healthcare delivery, and BD is committed to bringing secure, traceable storage as close to the patient as possible. The flexible, stackable device configuration of the Pyxis™ Pro Dispensing Solution offers more medication storage capacity in a similar footprint to improve medication availability from refrigerated to ambient storage, allowing hospitals and health systems to easily adapt to the evolving needs of their patient populations. It also offers enhanced security features to improve controlled substance management and more efficient access, with RFID badge scanning, wireless barcode scanners and illuminated bins to streamline medication retrieval.
Building on its established use in
Built on Amazon Web Services' (AWS) on-demand cloud computing infrastructure, the BD Incada™ Platform uses the latest in AI technologies, such as natural language search in analytics, and is scalable to meet the data volumes created by nearly three million smart connected BD devices. With BD Incada™ Analytics, clinicians have access to enterprise-wide visibility into medication inventory and user-customizable dashboards, which help clinicians identify patterns and ensure medication availability, reduce medication waste and improve labor efficiency.
In the European market, BD will leverage the AWS European Sovereign Cloud to allow EU Healthcare Systems to meet their digital sovereignty needs, without compromising on the performance, innovation, security, or scale of the AWS Cloud and the BD solutions.
"BD's innovations in medication management are setting a new standard for unified, data-driven healthcare operations," said
The Pyxis™ Pro Dispensing Solution will roll out across
